I
Itzhak Brook
Researcher at Georgetown University
Publications - 453
Citations - 15719
Itzhak Brook is an academic researcher from Georgetown University. The author has contributed to research in topics: Anaerobic bacteria & Peptostreptococcus. The author has an hindex of 63, co-authored 448 publications receiving 14710 citations. Previous affiliations of Itzhak Brook include Boston Children's Hospital & University of Washington.
Papers
More filters
Journal ArticleDOI
Pericarditis due to Anaerobic Bacteria
TL;DR: Treatment of pericarditis involving anaerobic bacteria includes the use of antibiotic therapy effective against these organisms and complete identification and testing for antimicrobial susceptibility and lactamase production are essential for the management of infections caused by these bacteria.
Journal ArticleDOI
Penicillin and clindamycin therapy in recurrent tonsillitis. Effect of microbial flora.
P.A. Foote,Itzhak Brook +1 more
TL;DR: The efficacy of clindamycin therapy in eradicating group A beta-hemolytic streptococci and beta-lactamase-producing bacteria from the tonsillar core in recurrent inflamed tonsils is illustrated, especially in persons aged 12 years old and younger.
Journal ArticleDOI
The role of anaerobic bacteria in upper respiratory tract and other head and neck infections
TL;DR: Management of anaerobic infection is complicated by the slow growth of these organisms, by their polymicrobial nature, and by their growing resistance to antimicrobials.
Journal ArticleDOI
Bacteriology and treatment of chronic otitis media.
TL;DR: Antimicrobial therapy directed against aerobic and anaerobic isolates from chronic otitis media had a high success rate in complete eradication of the infection.
Journal ArticleDOI
Role of methicillin-resistant Staphylococcus aureus in head and neck infections.
TL;DR: Treatment of head and neck infections associated with methicillin-resistant Staphylococcus aureus includes drainage and debridement, as well as administration of local and systemic antimicrobials that provide coverage against these organisms and against potential aerobic and anaerobic pathogens that may be present if the infection is polymicrobial.